^
Association details:
| Biomarker: | HYAL4 V1 |
|---|---|
| Cancer: | Bladder Cancer |
| Drug: | gemcitabine (DNA synthesis inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer
Published date:
05/24/2021
Excerpt:
V1-expressing bladder cells were resistant to Gemcitabine but not to Cisplatin.
DOI:
10.1158/1078-0432.CCR-21-0422
